SHMT1 and colorectal cancer: In our previous systematic review and recent literature search for pharmacogenetic studies of colorectal cancer patients treated with fluoropyrimidines, no other studies were identified that included an analysis of DHFR, SHMT or MTHFD1 genotypes.